Related Experiment Video

Updated: Aug 9, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

[From hypertension to heart failure-a pathophysiological continuum]

Heiko Kilter1, Michael Böhm

  • 1Innere Medizin III, Medizinische Universitätsklinik und Poliklinik der Universität des Saarlandes, Homburg/Saar. kilter@med-in.uni-sb.de

Herz
|May 29, 2004
PubMed

Insights

Heart failure is a common chronic disease, often caused by hypertension or myocardial infarction. Understanding the signaling pathways in cardiac hypertrophy is key to developing new heart failure treatments.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Context:

  • Heart failure is a prevalent chronic disease in Western countries with a poor prognosis.
  • Aging populations will increase the incidence and importance of heart failure.
  • Hypertension and myocardial infarction are primary causes, accounting for ~75% of cases.

Purpose:

  • To explore the mechanisms of cardiac hypertrophy induced by pressure overload.
  • To investigate the role of neuroendocrine systems, including the renin-angiotensin-aldosterone system and sympathetic nervous system.
  • To identify maladaptive signaling pathways in the transition from compensated hypertrophy to heart failure.

Summary:

  • Pressure overload in hypertension increases cardiac wall stress, leading to cardiomyocyte hypertrophy.
  • Cardiac hypertrophy is triggered by mechanical stress and neuroendocrine activation.
  • Myocardial hypertrophy is an independent risk factor for cardiovascular events and a predictor of heart failure.

Impact:

  • Identifying maladaptive signaling pathways is crucial for developing novel therapeutic strategies.
  • This research aims to improve the prevention and management of heart failure.
  • Understanding these pathways can lead to targeted treatments for heart failure patients.

More Related Videos

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...